VitaNova Life Sciences (VNOV) Receivables - Other (2019 - 2026)

VitaNova Life Sciences' (VNOV) quarterly Receivables - Other came in at -$172310.0 in Q1 2026, down 1375.61% on a QoQ basis from $13508.0 in Q4 2025.

VitaNova Life Sciences (VNOV) Receivables - Other (2019 - 2026) Analysis & Trends

VitaNova Life Sciences (VNOV) has 4 years of Receivables - Other data on file, last reported at -$172310.0 in Q1 2026.

Quarterly Receivables - Other changed N/A year-over-year to -$172310.0 in Q1 2026, while the trailing twelve-month figure through Apr 2026 was -$158802.0 (up 47.43% YoY) and the FY2026 annual result came in at -$158802.0, up 47.43% from the prior year.
Receivables - Other declined to -$172310.0 in Q1 2026, from $13508.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $460870.0 in Q2 2024 to a low of -$512980.0 in Q2 2025.
A 3-year average of $22285.7 and a median of $13508.0 in 2025 frame the typical range for Receivables - Other.
The widest YoY moves for Receivables - Other: up 108.02% in 2025, down 211.31% in 2025.
Tracing VNOV's Receivables - Other over 3 years: stood at -$168480.0 in 2024, then soared by 108.02% to $13508.0 in 2025, then sank by 1375.61% to -$172310.0 in 2026.
The last three Receivables - Other figures came in at -$172310.0 (Q1 2026), $13508.0 (Q4 2025), and -$512980.0 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Mckesson	102.57 Bn	97.41 Bn	3.69 Bn
2	Cencora	61.35 Bn	58.53 Bn	3.61 Bn
3	Cardinal Health	54.15 Bn	49.30 Bn	2.56 Bn
4	Henry Schein	10.05 Bn	9.89 Bn	1.10 Bn
5	Akso Health	671.90 Mn	671.70 Mn	-
6	Edap Tms	154.62 Mn	133.07 Mn	7.34 Mn
7	Accendra Health	90.69 Mn	83.04 Mn	263.41 Mn
8	111	31.31 Mn	-27.44 Mn	18.18 Mn
9	Cosmos Health	13.28 Mn	10.84 Mn	1.51 Mn
10	VitaNova Life Sciences	11.51 Mn	9.91 Mn	264,662.00

Download Data